Business Description
ISIN : US04638F1084
Total Employee Number:
398Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | 5.72 | |||||
Interest Coverage | 0.48 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.07 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.8 | |||||
3-Year EBITDA Growth Rate | -14.7 | |||||
3-Year EPS without NRI Growth Rate | -28.1 | |||||
3-Year Book Growth Rate | -4.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.15 | |||||
9-Day RSI | 73.35 | |||||
14-Day RSI | 78.96 | |||||
3-1 Month Momentum % | 88.17 | |||||
6-1 Month Momentum % | 217.07 | |||||
12-1 Month Momentum % | 176.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.76 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 164.91 | |||||
Days Sales Outstanding | 48.41 | |||||
Days Payable | 28.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.5 | |||||
Shareholder Yield % | 3.03 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.47 | |||||
Operating Margin % | 1.04 | |||||
Net Margin % | -0.89 | |||||
EBITDA Margin % | 4.33 | |||||
FCF Margin % | 6.61 | |||||
OCF Margin % | 6.81 | |||||
ROE % | -1.75 | |||||
ROA % | -0.95 | |||||
ROIC % | 1.24 | |||||
3-Year ROIIC % | 1660.56 | |||||
ROC (Joel Greenblatt) % | 2.78 | |||||
ROCE % | 1.9 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 93.52 | |||||
Shiller PE Ratio | 103.63 | |||||
Price-to-Owner-Earnings | 34.76 | |||||
PS Ratio | 1.46 | |||||
PB Ratio | 2.89 | |||||
Price-to-Tangible-Book | 5.65 | |||||
Price-to-Free-Cash-Flow | 22.2 | |||||
Price-to-Operating-Cash-Flow | 21.54 | |||||
EV-to-EBIT | 137.38 | |||||
EV-to-EBITDA | 39.5 | |||||
EV-to-Revenue | 1.71 | |||||
EV-to-FCF | 25.89 | |||||
Price-to-GF-Value | 2.19 | |||||
Price-to-Projected-FCF | 1.86 | |||||
Price-to-Median-PS-Value | 1.81 | |||||
Price-to-Graham-Number | 4.85 | |||||
| Price-to-Net-Current-Asset-Value | 18.12 | |||||
Earnings Yield (Greenblatt) % | 0.73 | |||||
FCF Yield % | 4.42 | |||||
Forward Rate of Return (Yacktman) % | 8.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALOT
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AstroNova Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 152.171 | ||
| EPS (TTM) ($) | -0.18 | ||
| Beta | 1.7296 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 1.39 | ||
| Volatility % | 96.88 | ||
| 14-Day RSI | 78.96 | ||
| 14-Day ATR ($) | 0.100082 | ||
| 20-Day SMA ($) | 28.91375 | ||
| 12-1 Month Momentum % | 176.56 | ||
| 52-Week Range ($) | 6.96 - 29 | ||
| Shares Outstanding (Mil) | 7.84 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AstroNova Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AstroNova Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2026-12-10 08:30 | In 103 days | ||
| Third quarter earnings results for 2027 | 2026-12-10 | In 102 days | ||
| General meeting for 2026 | 2026-12-02 09:00 | In 95 days | ||
| Second quarter earnings conference call for 2027 | 2026-09-09 10:00 | In 11 days | ||
| Second quarter earnings results for 2027 | 2026-09-09 | In 10 days | ||
| First quarter earnings conference call for 2027 | 2026-06-08 08:15 | 14.49 (-4.80%) | ||
| First quarter earnings results for 2027 | 2026-06-08 | 14.49 (-4.80%) | ||
| Annual report for 2026 | 2026-04-15 | 11.78 (+0.26%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-04-14 08:30 | 11.72 (+0.47%) | ||
| Fourth quarter earnings results for 2026 | 2026-04-13 | 11.57 (+0.00%) |
AstroNova Inc Frequently Asked Questions
Guru Commentaries on NAS:ALOT
AstroNova Inc. was acquired last week for $29/share, which we view as a successful outcome after a challenging period following their acquisition of MTEX. Despite initial frustrations, the new management team has effectively paid down debt, improved margins, and revitalized the aerospace business. Our initial expectation for a takeout price was in the $18-$24 range, but the eventual sale exceeded our expectations. The turnaround was significantly aided by activist involvement and strong leadership from the CFO, Tom Deboyle. Overall, we are pleased with the outcome and the returns generated from this investment.
Our investment in AstroNova Inc. was predicated on the view that it was a low-risk 'under-earner' with a clear path for earnings normalization. However, the acquisition of MTEX for $26 million, which was expected to contribute $3 million in EBITDA, has turned catastrophic, with MTEX now projected to lose $4 million annually. This acquisition has deepened our skepticism about the company's management and their capital allocation decisions. The lack of transparency and governance failures surrounding the MTEX deal have led to a significant decline in share price, from $18 to a low of $7.53, prompting us to trim our position.
Press Release
Articles on AstroNova Inc
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
